Evidence map›Paper›PMID 42094561›Full record

ArticlebioRxiv : the preprint server for biology2026

The

Theresa Karagöz, Ivan Ngueya Yango, Stefanie Norkowski, Yannick Teschke, Britta Körner, Joyleen Fernandes, Yvonne Boergeling, Petra Dersch, Christian Rüter

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Theresa KaragözInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Ivan Ngueya YangoInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Stefanie NorkowskiInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Yannick TeschkeInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Britta KörnerInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Joyleen FernandesInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Yvonne BoergelingInstitute of Molecular Virology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Petra DerschInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.
Christian RüterInstitute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial effector proteins manipulate host signalling cascades, including immune responses, to facilitate infection. While most effectors of Gram-negative bacteria rely on a secretion system for intracellular delivery, some possess intrinsic cell-penetrating capabilities. Here, we characterize the

Indexed as

bacterial cell-penetrating effector proteinsendocytosisendosomal escapeHost-pathogen interactionimmune evasionInflammasome signalingIpaHKinome profilingLPX effector protein familyNEL ubiquitin ligaseReactive oxygen species

Identifiers

PMID42094561
PMCPMC13142472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.